Literature DB >> 5437893

Mechanisms responsible for plasma levels of nafcillin lower than those of oxacillin.

A C Kind, T E Tupasi, H C Standiford, W M Kirby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5437893

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  14 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats.

Authors:  Kunio Fujiwara; Masashi Shin; Tsubasa Miyazaki; Yasuhiro Maruta
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

3.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 4.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

5.  Pharmacokinetics of nafcillin in patients with renal failure.

Authors:  C R Diaz; J G Kane; R H Parker; F R Pelsor
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

6.  Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1.

Authors:  H Uchino; I Tamai; H Yabuuchi; K China; K Miyamoto; E Takeda; A Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 7.  Pharmacokinetics of the penicillins in man.

Authors:  M Barza; L Weinstein
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus.

Authors:  Steven N Leonard; Megan E Supple; Ronak G Gandhi; Meghna D Patel
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

10.  Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.

Authors:  S M Smith; R H Eng
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.